Insider sale
RETINALGENIX TECHNOLOGIES INC.
$323.3K
98K shares
What this filing means
BAYERN STEVEN plans to sell 98K shares of RETINALGENIX TECHNOLOGIES INC. valued at approximately $323.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/7/2025ACC: 0001493152-25-021250
98K
Shares to sell
$323.3K
Approx. market value
4.21M
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
EXERCISE WARRANT
CHECK
9/1/2018
4.21MTotal acquired4.21M
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/1/2018 | EXERCISE WARRANT CHECK | 4.21M | — |
| Total | 4.21M | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
2.50K
Market value
$8.1K
10/31/2025
—Completed
Units to sell
10.10K
Market value
$36.8K
10/27/2025
—Completed
Units to sell
8K
Market value
$30.7K
10/24/2025
Planned — Approximate Date
OTCQBPlanned
Units to sell
77.40K
Market value
$247.7K
11/10/2025
Total
Units
98K
Value
$323.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
10/31/2025 | 2.50K | $8.1K | — | Completed |
10/27/2025 | 10.10K | $36.8K | — | Completed |
10/24/2025 | 8K | $30.7K | — | Completed |
| Planned — Approximate Date | ||||
11/10/2025 | 77.40K | $247.7K | OTCQB | Planned |
| Total | 98K | $323.3K | ||